Natera strikes deal in Hong Kong for prenatal test

12/17/2013 | GenomeWeb Daily News (free registration)

Natera has entered into a distribution deal with DiagCor for undisclosed terms. The deal calls for DiagCor to introduce Natera's Panorama prenatal test in Hong Kong. The blood-based assay is used for the noninvasive detection of trisomy 13, 18 and 21, as well as sex chromosome aneuploidies, triploidy and monosomy X.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN